Celldex Therapeutics
CLDX
#4558
Rank
NZ$2.91 B
Marketcap
$43.90
Share price
-0.94%
Change (1 day)
-4.07%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.93

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.02. In 2022 the company made an earnings per share (EPS) of -$4.00 a decrease over its 2021 EPS that were of -$2.75.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.93-1.67%
2022-$4.0045.73%
2021-$2.75-23.36%
2020-$3.58-41.05%
2019-$6.08-76.95%
2018-$26.3745.03%
2017-$18.18-42.54%
2016-$31.64-3.82%
2015-$32.90-0.76%
2014-$33.1529.41%
2013-$25.620%
2012-$25.62-9.73%
2011-$28.381312.5%
2010-$2.01-95.79%
2009-$47.68-49.64%
2008-$94.68-82.64%
2007-$545.49-44.98%
2006-$991.521270.83%
2005-$72.3333.33%
2004-$54.25-10%
2003-$60.27-16.67%
2002-$72.33-38.46%
2001-$117.54-4.88%
2000-$123.56-81.66%
1999-$673.57-87.2%
1998-$5,260206.39%
1997-$1,71713.02%
1996-$1,519

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.71 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.42-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$20.23 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.69-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.11-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.86-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.95-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA